![]() Cĥ.31 Flexibility training and balance training are recommended 2–3 times/week for older adults with diabetes. B Prolonged sitting should be interrupted every 30 minutes for blood glucose benefits. Shorter durations (minimum 75 minutes/week) of vigorous-intensity or interval training may be sufficient for younger and more physically fit individuals.ĥ.29 Adults with type 1 C and type 2 B diabetes should engage in 2–3 sessions/week of resistance exercise on nonconsecutive days.ĥ.30 All adults, and particularly those with type 2 diabetes, should decrease the amount of time spent in daily sedentary behavior. Cĥ.28 Most adults with type 1 C and type 2 B diabetes should engage in 150 minutes or more of moderate- to vigorous-intensity aerobic activity per week, spread over at least 3 days/week, with no more than 2 consecutive days without activity. ![]() ![]() If results are normal, testing should be repeated at a minimum of 3-year intervals, with consideration of more frequent testing depending on initial results and risk status.ĥ.27 Children and adolescents with type 1 or type 2 diabetes or prediabetes should engage in 60 minutes/day or more of moderate- or vigorous-intensity aerobic activity, with vigorous muscle-strengthening and bone-strengthening activities at least 3 days/week. For all other patients, testing should begin at age 35 years.ĥ. Women who were diagnosed with GDM should have lifelong testing at least every 3 years.Ĥ. Patients with prediabetes (A1C ≥5.7%, impaired glucose tolerance, or impaired fasting glucose]) should be tested yearly.ģ. Other clinical conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans)Ģ.HDL cholesterol level 250 mg/dL (2.82 mmol/L).Hypertension (≥140/90 mmHg or on therapy for hypertension).High-risk race/ethnicity (e.g., African American, Latino, Native American, Asian American, Pacific Islander).Testing should be considered in adults with overweight or obesity (BMI ≥25 kg/m 2 or ≥23 kg/m 2 in Asian Americans) who have one or more of the following risk factors:
0 Comments
Leave a Reply. |